EN
IT

Ecg Watch looks like a common wristwatch, but able to detect an electrocardiogram, which can be viewed on smartphone and shared with the cardiology service center. There are no adhesive contacts or wires and the analysis can be performed even when standing up, without the need to undress. The App available on Smartphones displays the ECG, and is able to detect both the heart rate and atrial fibrillation.

Patent status

SUBMITTED

Priority Number

2016IT-TO07420

Priority Date

18/10/2016

License

ITALY

Market

In Italy, the direct healthcare costs for cardiovascular diseases have been estimated at approximately €16 billion, to which must be added €5 billion incurred in terms
of indirect costs calculated as loss of productivity.
The chosen entry market is that of Piedmont, where 34,000 people die each year
from cardiovascular diseases; the clinical trials will be carried out with the various
Piedmont hospitals, which have already approved telemedicine.

Problem

According to ISTAT, in Italy, the cardiovascular disease mortality rate is equal to 786.4 per 100 thousand inhabitants (for both men and women). Among these pathologies, hypertension is estimated to cause 7.5 million deaths, i.e. 12.8% of overall deaths.

Current technologies limits / Solutions

Current technologies are either inaccurate or require advanced medical equipment to monitor patient health; in addition, portable solutions are typically not wearable. However, all the market available solutions require a certain degree of medical expertise to be used correctly.

Killer Application

The first application of the proposed technology is a non-invasive cuffless blood pressure monitor (see PoC project). The proposed technology can also acquire an electrocardiogram and monitoring heart rate and blood oxygenation; therefore, thanks to the artificial intelligence algorithms and the smartphone-based approach, the proposed device can be used as a wearable COVID-19 symptom detector connected with hospitals, even at a distance of hundreds of kilometers.

Technology and our solution

A wrist wearable device with specific sensors for acquiring various vital parameters regarding the heart health. The data acquired by the smart watch is sent to a smartphone app, which, using innovative artificial intelligence algorithms, is able to diagnose cardiovascular diseases.

Advantages

The proposed technology is non-invasive while, at the same time, as accurate as professional instrumentation. It is simple to use because it does not require medical experience, simply touch the device with a finger to start the acquisition. Finally, it is definitely low-cost when compared with the competitors.

Roadmap

Thanks to the PoC 50000€, 10 prototypes will be assembled and tested in an operational environment on 100 people (TRL 7). Subsequently, it is estimated that another300.000€ will be needed for the innovative startup foundation, the medical certification and produce the first 100 CE certified pieces.

TRL 1
TRL 1
Basic Principles
Basic principles tested
TRL 2
TRL 2
Formulation
Technology concept formulated
TRL 3
TRL 3
Proof of concept
Experimental proof of concept
TRL 4
TRL 4
Laboratory Prototype
Technology validated in lab
TRL 5
TRL 5
Prototype tested on pilot-scale/large-scale
Technology validated in relevant environment (industrially relevant environment in the case of key enabling technologies)
TRL 6
TRL 6
Commercial prototype
Technology demonstrated in relevant environment (industrially relevant environment in the case of key enabling technologies)
TRL 7
TRL 7
Real world validation
System prototype demonstration in operational/real-world environment
TRL 8
TRL 8
First complete and commercial product
System complete and qualified
TRL 9
TRL 9
Full commercial application
Actual system proven in commercial environment (competitive manufacturing in the case of key enabling technologies; or in space)

TRL

The team

SEE THE PATENT ON KNOWLEDGESHARE
Menu